SE435526B - Forfarande for utvinning av antibiotikumet tienamycin - Google Patents

Forfarande for utvinning av antibiotikumet tienamycin

Info

Publication number
SE435526B
SE435526B SE7513570A SE7513570A SE435526B SE 435526 B SE435526 B SE 435526B SE 7513570 A SE7513570 A SE 7513570A SE 7513570 A SE7513570 A SE 7513570A SE 435526 B SE435526 B SE 435526B
Authority
SE
Sweden
Prior art keywords
tienamycin
antibioticum
recovery
procedure
tienamycin antibioticum
Prior art date
Application number
SE7513570A
Other languages
English (en)
Swedish (sv)
Other versions
SE7513570L (sv
Inventor
R T Goegelman
F M Kahan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7513570L publication Critical patent/SE7513570L/xx
Publication of SE435526B publication Critical patent/SE435526B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE7513570A 1974-12-19 1975-12-02 Forfarande for utvinning av antibiotikumet tienamycin SE435526B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53438274A 1974-12-19 1974-12-19
US05/613,822 US4000161A (en) 1974-12-19 1975-09-18 Process for purifying thienamycin

Publications (2)

Publication Number Publication Date
SE7513570L SE7513570L (sv) 1976-06-21
SE435526B true SE435526B (sv) 1984-10-01

Family

ID=27064443

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7513570A SE435526B (sv) 1974-12-19 1975-12-02 Forfarande for utvinning av antibiotikumet tienamycin

Country Status (7)

Country Link
US (1) US4000161A (xx)
JP (1) JPS6048160B2 (xx)
CH (1) CH628680A5 (xx)
ES (1) ES443458A1 (xx)
HU (1) HU175264B (xx)
NL (1) NL7514165A (xx)
SE (1) SE435526B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839352A (en) * 1975-11-21 1989-06-13 Merck & Co., Inc. N-acyl derivatives of thienamycin
US4165379A (en) * 1975-11-21 1979-08-21 Merck & Co., Inc. N-acetyl thienamycin
US4162324A (en) * 1975-11-21 1979-07-24 Merck & Co., Inc. Antibiotics 890A1 and 890A3
US4168268A (en) * 1977-03-01 1979-09-18 Merck & Co., Inc. Process for isolating thienamycin
US4232030A (en) * 1977-09-15 1980-11-04 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone
US4150145A (en) * 1977-09-15 1979-04-17 Merck & Co., Inc. N-alkylated derivatives of thienamycin sulfoxide and sulfone
US4189493A (en) * 1977-12-28 1980-02-19 Merck & Co., Inc. N-heterocyclic derivatives of thienamycin
US4198338A (en) * 1978-03-13 1980-04-15 Merck & Co., Inc. Process for purifying thienamycin
DE3146190A1 (de) * 1981-11-21 1983-06-16 Hoechst Ag, 6230 Frankfurt Isolierung von chemisch instabilen antibiotika aus fermentationsloesungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics

Also Published As

Publication number Publication date
NL7514165A (nl) 1976-06-22
HU175264B (hu) 1980-06-28
CH628680A5 (de) 1982-03-15
JPS6048160B2 (ja) 1985-10-25
US4000161A (en) 1976-12-28
JPS51101991A (xx) 1976-09-08
SE7513570L (sv) 1976-06-21
ES443458A1 (es) 1977-09-16

Similar Documents

Publication Publication Date Title
SE428562B (sv) Forfarande for framstellning av purinderivat
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
BG26192A3 (bg) Метод за получаване на 3-арилокси-3-фенилпропиламини
NO145075C (no) Kontinuerlig fremgangsmaate til fremstilling av alkoksysilaner
SE7513085L (sv) Forfarande for framstellning av etrar
TR19139A (tr) Laktatdehidrojenazenin izoenzimlerinin hepbirden tesbitine mahsus usul
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE7505080L (sv) Forfarande for framstellning av butyndiol.
SE421921B (sv) Analogiforfarande for framstellning av pyridobensodiazepinoner
BG24539A3 (bg) Метод за получаване на 1-етил- за- субституирани - фенил - декахидроизохинолини
SE421612B (sv) Forfarande for framstellning av alfa-6-deoxi-5-hydroxitetracyklin
SE418292B (sv) Forfarande for framstellning av 5-aryl-2-furamidiner
SE435526B (sv) Forfarande for utvinning av antibiotikumet tienamycin
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE414926B (sv) Forfarande for framstellning av 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler
SE423230B (sv) Forfarande for utvinning av glycin eller beta-alanin
SE7513879L (sv) Forfarande for syntes av karbamider
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE431547B (sv) Forfarande for framstellning av 3-metylencefamsulfoxider
SU538660A3 (ru) Способ получени -трет.-бутиламинометил4-окси- -ксилол- -диола
SE7507482L (sv) Forfarande for framstellning av substituerade l-sulfonylbensimidazoler.
SE420097B (sv) Forfarande for framstellning av hydroxialkylxantiner

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7513570-7

Effective date: 19940610

Format of ref document f/p: F